Purpose: We aimed to construct of a nomogram to predict progression-free survival (PFS) in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) with risk stratification using computed tomography (CT) radiomics features and clinical factors. Patients and Methods: A total of 311 patients diagnosed with LA-NPC (stage III–IVa) at our hospital between 2010 and 2014 were included. The region of interest (ROI) of the primary nasopharyngeal mass was manually outlined. Independent sample t-test and LASSO-logistic regression were used for selecting the most predictive radiomics features of PFS, and to generate a radiomics signature. A nomogram was built with clinical factors and radiomics features, and the risk stratification model was tested accordingly. Results: In total, 20 radiomics features most associated with prognosis were selected. The radiomics nomogram, which integrated the radiomics signature and significant clinical factors, showed excellent performance in predicting PFS, with C-index of 0.873 (95% CI: 0.803∼ 0.943), which was better than that of the clinical nomogram (C-index, 0.729, 95% CI: 0.620∼ 0.838) as well as of the TNM staging system (C-index, 0.689, 95% CI: 0.592– 0.787) in validation cohort. The calibration curves and the decision curve analysis (DCA) plot obtained suggested satisfying accuracy and clinical utility of the model. The risk stratification tool was able to predict differences in prognosis of patients in different risk categories (p< 0.001). Conclusion: CT-based radiomics features, an in particular, radiomics nomograms, have the potential to become an accurate and reliable tool for assisting with prognosis prediction of LA-NPC.
1 June 2025 in Quantitative Imaging in Medicine and Surgery
Background: Locally advanced nasopharyngeal carcinoma (LANPC) is a common malignant tumor of the nasopharynx, characterized by poor prognosis and a high susceptibility to recurrence and metastasis after surgery. The aim of this study was to establish and validate a radiomics model based on clinicopathological data and magnetic resonance imaging (MRI) information to predict progression-free survival (PFS) in LANPC patients, and to reveal the internal prediction process of the model through SHapley Additive exPlanation (SHAP) and image visualization techniques. Methods: A total of 1,098 patients with pathologically and clinically diagnosed LANPC were recruited from three hospitals {training, n=700 [70% from hospitals I (Guangxi Medical University Cancer Hospital) and II (Wuzhou Red Cross Hospital)]; internal validation, n=300 (remaining 30%); and external validation, n=98 [hospital III (The Second Affiliated Hospital of Guangxi Medical University)]}. Univariate Cox analysis and least absolute shrinkage and selection operator (LASSO) Cox regression were used to select radiomics features. A combined model integrating the radiomics score (radscore) and important clinicopathological factors was constructed using the eXtreme Gradient Boosting (XGBoost) algorithm. SHAP and image visualization techniques were used for interpretability analysis of prognostic models. Results: Optimal predictive performance was observed in the combined model, which integrated the radscore and important clinicopathological factors [induction chemotherapy (IC), Epstein-Barr virus (EBV)-DNA, and albumin], with Harrell concordance index (C-index) values of 0.762, 0.729, and 0.752 in the training, internal, and external validation cohorts, respectively. Ten radiomics features with the highest predictive contributions were identified using the SHAP algorithm. Two LANPC patients with similar clinicopathological stages but distinct risk levels were selected to visualize the top three radiomics features, revealing notable pixel-level visual differences in the largest layer of the tumor images. Kaplan-Meier survival analysis revealed prognostic differences between low- and high-risk groups, and the model’s performance was stable across subgroups (all log-rank P<0.05). Conclusions: The interpretable model was able to accurately predict the PFS in LANPC patients. SHAP and image visualization techniques provided quantitative contribution values and image-level radiomics information, which could provide valuable additional information for individualized prognostic evaluation and clinical decision-making for patients with LANPC.
1 February 2025 in Journal of Hepatocellular Carcinoma
Purpose: This study aimed to develop a novel nomogram to predict recurrence-free survival (RFS) for microvascular invasion (MVI)-negative hepatocellular carcinoma (HCC) patients after curative resection. Patients and Methods: A total of 143 pathologically confirmed MVI-negative HCC patients were analyzed retrospectively. Baseline MRI features and inflammatory markers were collected. We used univariable and multivariable Cox regression analysis to identify the independent risk factors for RFS. And we established a nomogram based on significant MRI features and inflammatory marker. The receiver operating characteristic (ROC) curve, concordance index (C-index) and calibration curve were used to evaluate the predictive accuracy and discriminative ability of the nomogram. The decision curve analysis (DCA) was performed to validate the clinical utility of the nomogram. Results: In multivariate Cox regression analysis, neutrophil-to-lymphocyte ratio (NLR) (P = 0.018), tumor size (P = 0.002), and tumor capsule (P = 0.000) were independent significant variables associated with RFS. Nomogram with independent factors was developed and achieved a good C-index of 0.730 (95% confidence interval [CI]: 0.656– 0.804) for predicting RFS. In ROC analysis, the areas under curve of the nomogram for 1-, 3- and 5-year RFS prediction were 0.725, 0.784 and 0.798, respectively. The risk score calculated by nomogram could divide MVI-negative HCC patients into high-risk group or low-risk group (P < 0.0001). DCA analysis revealed that the nomogram could increase net benefit and exhibited a wider range of threshold probabilities by the risk stratification than the independent risk factors in the prediction of MVI-negative HCC recurrence. Conclusion: The nomogram prognostic model based on MRI features and NLR for predicting RFS showed high accuracy in MVI-negative HCC patients after curative resection. It can help clinicians make treatment decisions for MVI-negative HCC patients and identify high-risk patients for timely intervention. Plain Language Summary: The lack of prognostic studies for microvascular invasion (MVI)-negative HCC patients after hepatectomy poses a great challenge to clinical management. To bridge this gap, our team conducted extensive research and developed a customized prognostic nomogram specifically for this patient subgroup. We created a predictive model that relies on MRI features (tumor size and tumor capsule) and neutrophil-to-lymphocyte ratio (NLR). This model demonstrates high accuracy in predicting outcomes for MVI-negative HCC patients following curative resection. And our model aids clinicians in making treatment decisions for MVI-negative HCC patients and in identifying high-risk patients for timely intervention.
Objectives: This study aimed to develop a disease-free survival (DFS) prediction model incorporating radiomics and intratumor heterogeneity (ITH) scores for locally advanced nasopharyngeal carcinoma (LANPC), and to establish an anti-epidermal growth factor receptor (EGFR) therapy risk model. Materials and Methods: A retrospective analysis was conducted on 950 pathologically confirmed LANPC patients (training cohort: n = 632, including 81 receiving anti-EGFR therapy; test cohort: n = 318, including 47 receiving anti-EGFR therapy). All patients underwent 1.5 T MRI (T2-Weighted Imaging and contrast-enhanced T1-Weighted Imaging). Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) and support vector machine (SVM) survival algorithms. Subsequently, five predictive models were developed and compared: a Comprehensive Risk Model (CRM) integrating clinical features, ITH score, and radiomics score; an ITH-radiomics model (IRM); a standalone ITH model (ITHM); a standalone radiomics model (RM); and a clinical model (CM). Model performance was evaluated using the area under the curve (AUC) and the concordance index (C-index), and clinical utility was assessed with decision curve analysis. Finally, Kaplan-Meier analysis with the log-rank test compared survival between the model-defined risk groups. Additionally, the DeepSurv deep neural network was employed to simulate personalized treatment recommendations based on the patient's risk profile. Results: With median follow-ups of 73 months (training) and 68.1 months (test), disease progression occurred in 34.2% (216/632) and 36.5% (116/318) of cases, respectively. The CRM achieved the highest C-index value for assessing DFS in patients with LANPC, with values of 0.829 and 0.760 in the training and test cohorts, respectively. Patients who met the DeepSurv treatment recommendations had better DFS. Conclusion: The superior performance of the CRM supports its potential to enhance DFS prediction in LANPC and to inform anti-EGFR therapy selection.
Objectives: This study aimed to develop an interpretable 3-year disease-free survival risk prediction tool to stratify patients with stage II colorectal cancer (CRC) by integrating CT images and clinicopathological factors. Methods: A total of 769 patients with pathologically confirmed stage II CRC and disease-free survival (DFS) follow-up information were recruited from three medical centers and divided into training (n = 442), test (n = 190), and validation cohorts (n = 137). CT-based tumor radiomics features were extracted, selected, and used to calculate a Radscore. A combined model was developed using artificial neural network (ANN) algorithm, by integrating the Radscore with significant clinicoradiological factors to classify patients into high- and low-risk groups. Model performance was assessed using the area under the curve (AUC), and feature contributions were qualified using the Shapley additive explanation (SHAP) algorithm. Kaplan–Meier survival analysis revealed the prognostic stratification value of the risk groups. Results: Fourteen radiomics features and five clinicoradiological factors were selected to construct the radiomics and clinicoradiological models, respectively. The combined model demonstrated optimal performance, with AUCs of 0.811 and 0.846 in the test and validation cohorts, respectively. Kaplan–Meier curves confirmed effective patient stratification (p < 0.001) in both test and validation cohorts. A high Radscore, rough intestinal outer edge, and advanced age were identified as key prognostic risk factors using the SHAP. Conclusion: The combined model effectively stratified patients with stage II CRC into different prognostic risk groups, aiding clinical decision-making. Critical relevance statement: Integrating CT images with clinicopathological information can facilitate the identification of patients with stage II CRC who are most likely to benefit from adjuvant chemotherapy. Key Points: The effectiveness of adjuvant chemotherapy for stage II colorectal cancer remains debated. A combined model successfully identified high-risk stage II colorectal cancer patients. Shapley additive explanations enhance the interpretability of the model’s predictions. Graphical